Celadon Pharmaceuticals (LSE:CEL) Other Operating Expense : €7.32 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Other Operating Expense?

Celadon Pharmaceuticals's Other Operating Expense for the six months ended in Dec. 2023 was €3.14 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €7.32 Mil.

Celadon Pharmaceuticals's quarterly Other Operating Expense declined from Dec. 2022 (€4.27 Mil) to Jun. 2023 (€4.18 Mil) and declined from Jun. 2023 (€4.18 Mil) to Dec. 2023 (€3.14 Mil).

Celadon Pharmaceuticals's annual Other Operating Expense increased from Dec. 2021 (€3.18 Mil) to Dec. 2022 (€14.78 Mil) but then declined from Dec. 2022 (€14.78 Mil) to Dec. 2023 (€7.30 Mil).

Celadon Pharmaceuticals Other Operating Expense Historical Data

The historical data trend for Celadon Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals Other Operating Expense Chart

Celadon Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

0.27

3.18

14.78

7.30

Celadon Pharmaceuticals Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Operating Expense	Get a 7-Day Free Trial			1.97	10.65	4.27	4.18	3.14

Celadon Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €7.32 Mil.

Celadon Pharmaceuticals Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Celadon Pharmaceuticals's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Celadon Pharmaceuticals (LSE:CEL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

32-33 Cowcross Street, London, GBR, EC1M 6DF

Website

https://www.celadonpharma.co.uk

Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis.

Celadon Pharmaceuticals (LSE:CEL) Headlines

No Headlines